Resona Asset Management’s Gilead Sciences GILD Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q2
$50.6M Sell
400,627
-21,959
-5% -$2.89M 0.24% 80
2026
Q1
$58.7M Buy
422,586
+8,508
+2% +$1.19M 0.29% 67
2025
Q4
$51M Sell
414,078
-14,834
-3% -$1.8M 0.25% 79
2025
Q3
$47.7M Sell
428,912
-21,232
-5% -$2.41M 0.23% 87
2025
Q2
$49.9M Buy
450,144
+7,426
+2% +$790K 0.24% 81
2025
Q1
$49.6M Buy
442,718
+11,696
+3% +$1.21M 0.29% 68
2024
Q4
$39.9M Sell
431,022
-26,265
-6% -$2.36M 0.24% 81
2024
Q3
$38.3M Sell
457,287
-8,932
-2% -$682K 0.22% 88
2024
Q2
$32M Sell
466,219
-66,588
-12% -$4.44M 0.19% 105
2024
Q1
$39M Buy
+532,807
New +$41M 0.23% 90

Other funds holding GILD

Resona Asset Management's GILD Position: Q2 2026 in Review

Resona Asset Management reduced its Gilead Sciences (GILD) stake by 5.2% in Q2 2026, selling an estimated $2.89M and leaving 400,627 shares worth $50.6M. The position accounts for 0.24% of the portfolio, ranked #80.

Resona Asset Management first reported a position in GILD in Q1 2024 and has held it in 10 quarters since. The position peaked at $58.7M in Q1 2026. 2,268 funds tracked by Wall St. Rank hold GILD as of Q2 2026.

  • Resona Asset Management held 400,627 shares of Gilead Sciences worth $50.6M as of Q2 2026.
  • Resona Asset Management sold 21,959 Gilead Sciences shares in Q2 2026, an estimated $2.89M.
  • Gilead Sciences made up 0.24% of Resona Asset Management's portfolio in Q2 2026, its #80 holding.
  • Resona Asset Management first reported a position in Gilead Sciences in Q1 2024 and has held it in 10 quarters since.
  • Resona Asset Management's Gilead Sciences position peaked at $58.7M in Q1 2026.
  • 2,268 funds tracked by Wall St. Rank held Gilead Sciences as of Q2 2026.

Based on Resona Asset Management's 13F filing for Q2 2026, filed 29 Jul 2026.